×
40 249
Fashion Jobs
AVEDA
Aveda Advisor - 15 Hrs - Shops at Columbus Circle - New York,ny
Permanent · New York
SHOW MY LINE
Women's Luxury Ready-tO-Wear Production Manager
Permanent · NEW YORK
ESTÉE LAUDER COMPANIES
Latam E-Commerce Project Manager/Product Owner
Permanent · New York
MICHAEL KORS RETAIL INC
Sales Supervisor, Crabtree Valley, Raleigh nc
Permanent · Raleigh
GAP
General Manager - Lenox Square (Kids & Baby)
Permanent · Atlanta
GAP
General Manager - Northbrook Court
Permanent · Northbrook
GAP
General Manager- Stonebriar Mall
Permanent · Frisco
GAP
General Manager - Roseville Galleria
Permanent · Roseville
GAP
General Manager - Central Texas Marketplace
Permanent · Waco
GAP
Merchandise Planner - Boys - Outlet
Permanent · New York
GAP
Unassigned General Manager - Greater Nashville
Permanent · Nashville
ALICE AND OLIVIA
Sales Supervisor - Cabazon Outlet
Permanent · Cabazon
TARGET CORPORATION
Owned Brand Product Design Director, Pets
Permanent · MINNEAPOLIS
LA MER
Manager, Global Supply Chain Operations - Inventory
Permanent · New York
MAC
Business Development – Key Consumer Manager, Mac
Permanent · New York
H&M
Retail Flagship Visual Manager
Permanent · Chicago
JBCSTYLE
Art Director
Permanent · NEW YORK
JBCSTYLE
Sales Operations Coordinator
Permanent · NEW YORK
ESTÉE LAUDER COMPANIES
Manager, Solution Architect- Omni Retail
Permanent · New York
TOM FORD BEAUTY
Vice President, Marketing, Tom Ford Beauty North America
Permanent · New York
ESTÉE LAUDER COMPANIES
Category Insights Manager - Supply Chain
Permanent · New York
ESTÉE LAUDER COMPANIES
Senior Account Coordinator, Estee Lauder Travel Retail – Americas
Permanent · Los Angeles

J&J forecasts disappointing 2019 sales, defends talc safety

By
Reuters
Published
today Jan 22, 2019
Reading time
access_time 2 minutes
Share
Download
Download the article
Print
Click here to print
Text size
aA+ aA-

Johnson & Johnson on Tuesday forecast 2019 sales that fell short of analysts’ estimates as the healthcare conglomerate faces increasing competition for some of its older drugs.


Reuters on Dec. 14 published a special report detailing that the company knew for decades that cancer-causing asbestos could be found in the company's Baby Powder - Reuters


J&J said it expects full-year sales of $80.4 billion to $81.2 billion, below Wall Street estimates of $82.69 billion, according to IBES data from Refinitiv.

Strength in the pharmaceuticals business helped offset higher costs, including a doubling of litigation expense in the fourth quarter to $1.29 billion.

Most of that was related to resolving older lawsuits in its medical devices business, spokesman Ernie Knewitz said in an email response to Reuters. For the full year, litigation expenses rose to $1.9 billion from $1.3 billion in 2017. About 10 percent of that total was related to talc, Knewitz said.

J&J is facing more than 11,000 lawsuits over the safety of talc in its products, including baby powder, alleging that its use caused cancer.

“We remain committed to ensuring the facts about our talc are understood and we will continue to defend the safety of our products,” Gorsky said.

Reuters on Dec. 14 published a special report detailing that the company knew for decades that cancer-causing asbestos could be found in its talc.

J&J has repeatedly said that its talc products are safe, and that decades of studies have shown them to be asbestos-free and that they do not cause cancer.

Sales in the quarter rose about 1 percent to $20.39 billion, topping Wall Street estimates of $20.20 billion.
 

© Thomson Reuters 2019 All rights reserved.